Medication Compliance, the New C. Diff
For hospitalists the implications for this study are certainly important. We need to be aware of whether this strain is prevalent in our work environment. Close collaboration with our colleagues from infectious disease services along with monitoring clinical outcomes of patients with Clostridium difficile infection is the need of the hour. Also recommended is investigation of any increases in caseload of this infection. Simple measures such as judicious use of antibiotics, early diagnosis, and appropriate treatment of Clostridium difficile infection and strict isolation of the patients infected or colonized with Clostridium difficile would go a long way in controlling the spread of the new more virulent strain. It must be pointed out that alcohol-based waterless hand-sanitizing agents do not kill the Clostridium difficile spores; washing hands with soap and water is a prudent option after coming in contact with a patient with Clostridium difficile. TH
Dr. Schimmel was the chief resident at Yale from 1960 to 1961. It is during that period that he designed the research project. This report stands out as a landmark study in the measurement of quality of care. The study was done at a time when economics of healthcare did not grab headlines, the average cost of one day of hospitalization was under $70, and medicine was practiced with a “doctor knows best” attitude.
One of the most important findings from this study was that the adverse events did not, by themselves, account for the increased length of stay. In fact, the prolonged hospitalization predisposed patients to higher adverse events—a fact that was nothing short of a revelation. Physicians were now forced to consider risk of hospitalization as a factor in deciding whether an admission was warranted for medical care.
Dr. Schimmel’s study pointed out that, with increasing severity of illness, patients received more diagnostic tests and therapeutic interventions, thereby increasing the risk for adverse events. The study also brought into focus the need to discuss and analyze the overall risk–benefit ratio for each procedure or intervention. One of the drawbacks of this study is that it did not take into account adverse events from medical errors. One can only speculate that the actual percentage of adverse events might have been higher than 20%.
A similar study that looked at iatrogenic adverse events done at Boston University Medical Center in 1979 revealed an adverse event rate of 36%. With increasing complexity of medical care, an aging population base (the average age of the patient in Dr. Schimmel’s study was 53), and less-than-ideal information management, this study remains a beacon to all of us who are committed to the principle of “do no harm.”
A system of voluntary reporting of all adverse events, including those from medical errors, should be developed and information shared by all the stakeholders (including patients and their families) in an effort to ameliorate the hazards of hospitalization. To this end the Institute of Healthcare Improvement’s “100K Lives” campaign brings much needed attention on this important issue.—SS
Resources
- Qual Saf Health Care. 2003;12:58-63; discussion 63-64.
- Steel K, Gertman PM, Crescenzi C, et al. Iatrogenic illness on a general medical service in a university hospital. N Eng J Med. 1981;304:638-642.
